<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although patients undergoing cardiac surgery often present with diverse comorbidities, those with coagulation derangements are especially challenging </plain></SENT>
<SENT sid="1" pm="."><plain>The present report describes the management of a patient who presented with a <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">Factor V Leiden mutation</z:e>, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, and acquired activated protein C resistance </plain></SENT>
<SENT sid="2" pm="."><plain>A 42-year-old female presented with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001954'>shortness of breath</z:mp> and <z:hpo ids='HP_0100749'>chest pain</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>She was otherwise healthy 1 month prior to admission when she presented with dysfunctional uterine <z:mp ids='MP_0001914'>bleeding</z:mp>, resulting in the transfusion of three units of packed red blood cells </plain></SENT>
<SENT sid="4" pm="."><plain>Coagulation evaluation revealed that the patient had <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> and an activated protein C resistance </plain></SENT>
<SENT sid="5" pm="."><plain>The patient presented with an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and was found to have 90% stenosis of her left main coronary artery, moderate mitral and <z:hpo ids='HP_0005180'>tricuspid regurgitation</z:hpo>, and a left ventricular ejection fraction of 25% </plain></SENT>
<SENT sid="6" pm="."><plain>An emergent off-pump coronary artery bypass procedure with placement of a vein graft to the left anterior descending artery was completed </plain></SENT>
<SENT sid="7" pm="."><plain>Intraoperative <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> was encountered as evidenced by both an elevated thromboelastograph coagulation index (+3.6) and an acquired <z:hpo ids='HP_0001976'>antithrombin-III deficiency</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Postoperatively, the patient was placed on low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi>, but developed <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> and was switched to a direct thrombin inhibitor, argatroban </plain></SENT>
<SENT sid="9" pm="."><plain>The following case report describes the coagulation management of this patient from the time of admission to discharge 43 days later, and the unique challenges this combination of hemostatic defects present to the clinicians </plain></SENT>
</text></document>